Global Male Hypogonadism Industry Research Report 2021 Segmented by Major Market Players, Types, Applications and Countries Forecast to 2027
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
The global Male Hypogonadism market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2020 to 2027, based on newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
By Market Verdors:
Astrazeneca Plc.
Merck & Co. Inc.
Laboratories Genevrier
Allergan Plc.
Endo International Plc.
Ferring
AbbVie Inc.
Eli Lilly and Company Ltd.
Finox Biotech
Teva Pharmaceutical Industries Ltd.
Bayer AG
IBSA Institut Biochimque
By Types:
Testosterone Replacement Therapy
Gonadotropin-Releasing Hormones Therapy
By Applications:
Kallmann Syndrome
Klinefelters Syndrome
Pituitary Disorders
Others
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
1 Report Overview
1.1 Study Scope and Definition
1.2 Research Methodology
1.2.1 Methodology/Research Approach
1.2.2 Data Source
1.3 Key Market Segments
1.4 Players Covered: Ranking by Male Hypogonadism Revenue
1.5 Market Analysis by Type
1.5.1 Global Male Hypogonadism Market Size Growth Rate by Type: 2021 VS 2027
1.5.2 Testosterone Replacement Therapy
1.5.3 Gonadotropin-Releasing Hormones Therapy
1.6 Market by Application
1.6.1 Global Male Hypogonadism Market Share by Application: 2022-2027
1.6.2 Kallmann Syndrome
1.6.3 Klinefelters Syndrome
1.6.4 Pituitary Disorders
1.6.5 Others
1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections
1.7.2 Covid-19 Impact: Commodity Prices Indices
1.7.3 Covid-19 Impact: Global Major Government Policy
1.8 Study Objectives
1.9 Years Considered
2 Global Male Hypogonadism Market Trends and Growth Strategy
2.1 Market Top Trends
2.2 Market Drivers
2.3 Market Challenges
2.4 Porter’s Five Forces Analysis
2.5 Market Growth Strategy
2.6 SWOT Analysis
3 Global Male Hypogonadism Market Players Profiles
3.1 Astrazeneca Plc.
3.1.1 Astrazeneca Plc. Company Profile
3.1.2 Astrazeneca Plc. Male Hypogonadism Product Specification
3.1.3 Astrazeneca Plc. Male Hypogonadism Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.2 Merck & Co. Inc.
3.2.1 Merck & Co. Inc. Company Profile
3.2.2 Merck & Co. Inc. Male Hypogonadism Product Specification
3.2.3 Merck & Co. Inc. Male Hypogonadism Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.3 Laboratories Genevrier
3.3.1 Laboratories Genevrier Company Profile
3.3.2 Laboratories Genevrier Male Hypogonadism Product Specification
3.3.3 Laboratories Genevrier Male Hypogonadism Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 Allergan Plc.
3.4.1 Allergan Plc. Company Profile
3.4.2 Allergan Plc. Male Hypogonadism Product Specification
3.4.3 Allergan Plc. Male Hypogonadism Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Endo International Plc.
3.5.1 Endo International Plc. Company Profile
3.5.2 Endo International Plc. Male Hypogonadism Product Specification
3.5.3 Endo International Plc. Male Hypogonadism Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 Ferring
3.6.1 Ferring Company Profile
3.6.2 Ferring Male Hypogonadism Product Specification
3.6.3 Ferring Male Hypogonadism Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 AbbVie Inc.
3.7.1 AbbVie Inc. Company Profile
3.7.2 AbbVie Inc. Male Hypogonadism Product Specification
3.7.3 AbbVie Inc. Male Hypogonadism Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Eli Lilly and Company Ltd.
3.8.1 Eli Lilly and Company Ltd. Company Profile
3.8.2 Eli Lilly and Company Ltd. Male Hypogonadism Product Specification
3.8.3 Eli Lilly and Company Ltd. Male Hypogonadism Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Finox Biotech
3.9.1 Finox Biotech Company Profile
3.9.2 Finox Biotech Male Hypogonadism Product Specification
3.9.3 Finox Biotech Male Hypogonadism Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Teva Pharmaceutical Industries Ltd.
3.10.1 Teva Pharmaceutical Industries Ltd. Company Profile
3.10.2 Teva Pharmaceutical Industries Ltd. Male Hypogonadism Product Specification
3.10.3 Teva Pharmaceutical Industries Ltd. Male Hypogonadism Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 Bayer AG
3.11.1 Bayer AG Company Profile
3.11.2 Bayer AG Male Hypogonadism Product Specification
3.11.3 Bayer AG Male Hypogonadism Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 IBSA Institut Biochimque
3.12.1 IBSA Institut Biochimque Company Profile
3.12.2 IBSA Institut Biochimque Male Hypogonadism Product Specification
3.12.3 IBSA Institut Biochimque Male Hypogonadism Production Capacity, Revenue, Price and Gross Margin (2016-2021)
4 Global Male Hypogonadism Market Competition by Market Players
4.1 Global Male Hypogonadism Production Capacity Market Share by Market Players (2016-2021)
4.2 Global Male Hypogonadism Revenue Market Share by Market Players (2016-2021)
4.3 Global Male Hypogonadism Average Price by Market Players (2016-2021)
5 Global Male Hypogonadism Production by Regions (2016-2021)
5.1 North America
5.1.1 North America Male Hypogonadism Market Size (2016-2021)
5.1.2 Male Hypogonadism Key Players in North America (2016-2021)
5.1.3 North America Male Hypogonadism Market Size by Type (2016-2021)
5.1.4 North America Male Hypogonadism Market Size by Application (2016-2021)
5.2 East Asia
5.2.1 East Asia Male Hypogonadism Market Size (2016-2021)
5.2.2 Male Hypogonadism Key Players in East Asia (2016-2021)
5.2.3 East Asia Male Hypogonadism Market Size by Type (2016-2021)
5.2.4 East Asia Male Hypogonadism Market Size by Application (2016-2021)
5.3 Europe
5.3.1 Europe Male Hypogonadism Market Size (2016-2021)
5.3.2 Male Hypogonadism Key Players in Europe (2016-2021)
5.3.3 Europe Male Hypogonadism Market Size by Type (2016-2021)
5.3.4 Europe Male Hypogonadism Market Size by Application (2016-2021)
5.4 South Asia
5.4.1 South Asia Male Hypogonadism Market Size (2016-2021)
5.4.2 Male Hypogonadism Key Players in South Asia (2016-2021)
5.4.3 South Asia Male Hypogonadism Market Size by Type (2016-2021)
5.4.4 South Asia Male Hypogonadism Market Size by Application (2016-2021)
5.5 Southeast Asia
5.5.1 Southeast Asia Male Hypogonadism Market Size (2016-2021)
5.5.2 Male Hypogonadism Key Players in Southeast Asia (2016-2021)
5.5.3 Southeast Asia Male Hypogonadism Market Size by Type (2016-2021)
5.5.4 Southeast Asia Male Hypogonadism Market Size by Application (2016-2021)
5.6 Middle East
5.6.1 Middle East Male Hypogonadism Market Size (2016-2021)
5.6.2 Male Hypogonadism Key Players in Middle East (2016-2021)
5.6.3 Middle East Male Hypogonadism Market Size by Type (2016-2021)
5.6.4 Middle East Male Hypogonadism Market Size by Application (2016-2021)
5.7 Africa
5.7.1 Africa Male Hypogonadism Market Size (2016-2021)
5.7.2 Male Hypogonadism Key Players in Africa (2016-2021)
5.7.3 Africa Male Hypogonadism Market Size by Type (2016-2021)
5.7.4 Africa Male Hypogonadism Market Size by Application (2016-2021)
5.8 Oceania
5.8.1 Oceania Male Hypogonadism Market Size (2016-2021)
5.8.2 Male Hypogonadism Key Players in Oceania (2016-2021)
5.8.3 Oceania Male Hypogonadism Market Size by Type (2016-2021)
5.8.4 Oceania Male Hypogonadism Market Size by Application (2016-2021)
5.9 South America
5.9.1 South America Male Hypogonadism Market Size (2016-2021)
5.9.2 Male Hypogonadism Key Players in South America (2016-2021)
5.9.3 South America Male Hypogonadism Market Size by Type (2016-2021)
5.9.4 South America Male Hypogonadism Market Size by Application (2016-2021)
5.10 Rest of the World
5.10.1 Rest of the World Male Hypogonadism Market Size (2016-2021)
5.10.2 Male Hypogonadism Key Players in Rest of the World (2016-2021)
5.10.3 Rest of the World Male Hypogonadism Market Size by Type (2016-2021)
5.10.4 Rest of the World Male Hypogonadism Market Size by Application (2016-2021)
6 Global Male Hypogonadism Consumption by Region (2016-2021)
6.1 North America
6.1.1 North America Male Hypogonadism Consumption by Countries
6.1.2 United States
6.1.3 Canada
6.1.4 Mexico
6.2 East Asia
6.2.1 East Asia Male Hypogonadism Consumption by Countries
6.2.2 China
6.2.3 Japan
6.2.4 South Korea
6.3 Europe
6.3.1 Europe Male Hypogonadism Consumption by Countries
6.3.2 Germany
6.3.3 United Kingdom
6.3.4 France
6.3.5 Italy
6.3.6 Russia
6.3.7 Spain
6.3.8 Netherlands
6.3.9 Switzerland
6.3.10 Poland
6.4 South Asia
6.4.1 South Asia Male Hypogonadism Consumption by Countries
6.4.2 India
6.5 Southeast Asia
6.5.1 Southeast Asia Male Hypogonadism Consumption by Countries
6.5.2 Indonesia
6.5.3 Thailand
6.5.4 Singapore
6.5.5 Malaysia
6.5.6 Philippines
6.6 Middle East
6.6.1 Middle East Male Hypogonadism Consumption by Countries
6.6.2 Turkey
6.6.3 Saudi Arabia
6.6.4 Iran
6.6.5 United Arab Emirates
6.7 Africa
6.7.1 Africa Male Hypogonadism Consumption by Countries
6.7.2 Nigeria
6.7.3 South Africa
6.8 Oceania
6.8.1 Oceania Male Hypogonadism Consumption by Countries
6.8.2 Australia
6.9 South America
6.9.1 South America Male Hypogonadism Consumption by Countries
6.9.2 Brazil
6.9.3 Argentina
6.10 Rest of the World
6.10.1 Rest of the World Male Hypogonadism Consumption by Countries
7 Global Male Hypogonadism Production Forecast by Regions (2022-2027)
7.1 Global Forecasted Production of Male Hypogonadism (2022-2027)
7.2 Global Forecasted Revenue of Male Hypogonadism (2022-2027)
7.3 Global Forecasted Price of Male Hypogonadism (2022-2027)
7.4 Global Forecasted Production of Male Hypogonadism by Region (2022-2027)
7.4.1 North America Male Hypogonadism Production, Revenue Forecast (2022-2027)
7.4.2 East Asia Male Hypogonadism Production, Revenue Forecast (2022-2027)
7.4.3 Europe Male Hypogonadism Production, Revenue Forecast (2022-2027)
7.4.4 South Asia Male Hypogonadism Production, Revenue Forecast (2022-2027)
7.4.5 Southeast Asia Male Hypogonadism Production, Revenue Forecast (2022-2027)
7.4.6 Middle East Male Hypogonadism Production, Revenue Forecast (2022-2027)
7.4.7 Africa Male Hypogonadism Production, Revenue Forecast (2022-2027)
7.4.8 Oceania Male Hypogonadism Production, Revenue Forecast (2022-2027)
7.4.9 South America Male Hypogonadism Production, Revenue Forecast (2022-2027)
7.4.10 Rest of the World Male Hypogonadism Production, Revenue Forecast (2022-2027)
7.5 Forecast by Type and by Application (2022-2027)
7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
7.5.2 Global Forecasted Consumption of Male Hypogonadism by Application (2022-2027)
8 Global Male Hypogonadism Consumption Forecast by Regions (2022-2027)
8.1 North America Forecasted Consumption of Male Hypogonadism by Country
8.2 East Asia Market Forecasted Consumption of Male Hypogonadism by Country
8.3 Europe Market Forecasted Consumption of Male Hypogonadism by Countriy
8.4 South Asia Forecasted Consumption of Male Hypogonadism by Country
8.5 Southeast Asia Forecasted Consumption of Male Hypogonadism by Country
8.6 Middle East Forecasted Consumption of Male Hypogonadism by Country
8.7 Africa Forecasted Consumption of Male Hypogonadism by Country
8.8 Oceania Forecasted Consumption of Male Hypogonadism by Country
8.9 South America Forecasted Consumption of Male Hypogonadism by Country
8.10 Rest of the world Forecasted Consumption of Male Hypogonadism by Country
9 Global Male Hypogonadism Sales by Type (2016-2027)
9.1 Global Male Hypogonadism Historic Market Size by Type (2016-2021)
9.2 Global Male Hypogonadism Forecasted Market Size by Type (2022-2027)
10 Global Male Hypogonadism Consumption by Application (2016-2027)
10.1 Global Male Hypogonadism Historic Market Size by Application (2016-2021)
10.2 Global Male Hypogonadism Forecasted Market Size by Application (2022-2027)
11 Global Male Hypogonadism Manufacturing Cost Analysis
11.1 Male Hypogonadism Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.3 Manufacturing Process Analysis of Male Hypogonadism
12 Global Male Hypogonadism Marketing Channel, Distributors, Customers and Supply Chain
12.1 Marketing Channel
12.2 Male Hypogonadism Distributors List
12.3 Male Hypogonadism Customers
12.4 Male Hypogonadism Supply Chain Analysis
13 Analyst's Viewpoints/Conclusions
14 Disclaimer
Research Methodology:
Male Hypogonadism Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|